ADHD in the News 2022-10-13
OHSU researchers sharpen estimate of true percentage of people with ADHD
Researchers at Oregon Health & Science University estimate the true percentage of people with Attention-Deficit/Hyperactivity Disorder, or ADHD, in the United States is approximately 3.5% of the population — substantially lower than many common estimates. The study, published this month in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), also found that more than half of children with ADHD had a co-occurring mental disorder.
U.S. FDA warns of ADHD drug Adderall shortage on Teva manufacturing delays
Oct 12 (Reuters) - The U.S. Food and Drug Administration said on Wednesday there was a shortage of Adderall, a treatment for attention deficit hyperactivity disorder, following intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (TEVA.TA).
Annual Stimulant Prescriptions Have Doubled In Adolescents Since 2008
Prescriptions for controlled stimulants among adolescents and young adults have increased significantly in the US since 2008. In a new research letter assessing the recent trends of controlled medication prescriptions for young Americans, a team of Boston investigators observed a substantial increase in stimulants among adolescents aged 13-18 years old and young adults aged 19-25 years old. Though the total prescriptions peaked in 2016, the trajectory of annual stimulant prescriptions in these age groups remained approximately twice greater than it was in 2008.
ADHD label may increase risk of self-harm in teens, study suggests
Oct. 13 (UPI) -- Diagnosing attention-deficit/hyperactivity disorder, or ADHD, in adolescents doesn't improve their self-reported quality of life compared with teens with similar behaviors but no diagnosis. And it may significantly increase their risk of self-harm.
Understanding the Long-Term Clinical Course of Comorbid SUD and ADHD
Comorbid SUD and ADHD is associated with more severe illness. What do we understand about these comorbid conditions and what do we still need to learn?
ADHD Drugs Negatively Affect Bone Density
A recent study investigated the effect of psychostimulants modafinil, atomoxetine, and guanfacine on the differentiation of mesenchymal stem cells to osteoblasts and on their cell functions, including migration. Researchers determined that the 3 medications commonly used to treat attention-deficit/hyperactivity disorder (ADHD) negatively affect hMSC differentiation to bone-forming osteoblasts and cell migration through different intracellular pathways.(1)
Human cells in a rat’s brain could shed light on autism and ADHD
Scientists have demonstrated a new way to study conditions like autism spectrum disorder, ADHD, and schizophrenia. The approach involves transplanting a cluster of living human brain cells from a dish in the lab to the brain of a newborn rat, a team from Stanford University reports in the journal Nature.
Cardiovascular and Other Health Risks for Adults With ADHD
KEY POINTS: A recent study showed ADHD is associated with a higher risk of cardiovascular disease compared with controls. Though the danger is high for both men and women, males and young adults are at somewhat higher risk. The most common risks are for cardiac arrest, stroke, and peripheral vascular disease/arteriosclerosis. The cognitive and physical benefits of exercise for adult ADHD are well-documented, but these new findings stress its importance for well-being.
Patient Case #2: Dealing With Comorbidities in Adult ADHD
Around the Practice: Management of Adult with Attention Deficit/Hyperactivity Disorder (ADHD) - Episode 14. Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss how to deal with other comorbidities when treating an adult with ADHD.